The objective of this study was to examine markers of whole-body and muscle protein metabolism in aged horses fed a diet typical for North American aged horses, supplemented with amino acids. In a replicated Latin square design, six aged horses (20 ± 1.1 years) were studied while receiving each of three isocaloric, isonitrogenous whole-body rates of protein synthesis and degradation. There was no effect of treatment on relative abundance of proteins involved in protein synthesis, nitrogen retention or phenylalanine kinetics. PUN concentrations tended to be higher for LYS/THR (p = 0.054) and were higher for LYS/THR/MET (p = 0.0056) than for CON. Atrogin-1 abundance tended to be higher in the post-absorptive state for the CON treatment (p = 0.07), indicating that amino acid supplementation resulted in less muscle protein degradation when horses were in the post-absorptive state. However, lack of differences in nitrogen retention and phenylalanine kinetics indicated that whole-body protein metabolism was not improved, and higher PUN concentrations in the supplemented diets suggest that the supplemented amino acids may have been catabolized. Amino acid availability was not limiting protein synthesis in the sedentary aged horses in this study when fed the CON diet.
methionine).
In each 15-days period, urine and faeces were collected for assessment of nitrogen balance. Blood samples were collected before and after feeding for analysis of plasma urea nitrogen (PUN), glucose, insulin and plasma amino acid concentrations. Skeletal muscle samples were collected for measurement of proteins associated with muscle protein synthesis and degradation, and horses underwent stable isotope infusion procedures for comparison of differences in whole-body rates of protein synthesis and degradation. There was no effect of treatment on relative abundance of proteins involved in protein synthesis, nitrogen retention or phenylalanine kinetics. PUN concentrations tended to be higher for LYS/THR (p = 0.054) and were higher for LYS/THR/MET (p = 0.0056) than for CON. Atrogin-1 abundance tended to be higher in the post-absorptive state for the CON treatment (p = 0.07), indicating that amino acid supplementation resulted in less muscle protein degradation when horses were in the post-absorptive state. However, lack of differences in nitrogen retention and phenylalanine kinetics indicated that whole-body protein metabolism was not improved, and higher PUN concentrations in the supplemented diets suggest that the supplemented amino acids may have been catabolized. Amino acid availability was not limiting protein synthesis in the sedentary aged horses in this study when fed the CON diet.
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| INTRODUC TI ON
The aged horse population in the United States is growing, with horses older than 20 years of age comprising approximately 11% of the equine population in the United States (APHIS, 2015) . This is a four per cent increase from the estimates made in 2005 (APHIS, 2005) , suggesting that the aged equine population is increasing, and therefore, age-related illnesses may become more of a concern.
Age-related muscle loss has been observed in horses (Hintz, 1995; Rich, 1989) , although it is not currently known whether supplementation with amino acids could improve the symptoms of muscle loss.
Skeletal muscle protein synthetic processes can be limited by availability of amino acids. When essential amino acids are not available at sufficient levels to support protein synthesis, protein synthesis is constrained by the amino acid that is present in the diet the furthest below the animal's requirement, the limiting amino acid. If the amount of the limiting amino acid is increased, the level of protein synthesis can be increased proportionally until the amino acid of interest is no longer limiting. Therefore, it has been suggested that supplementation of suspected limiting amino acids could decrease the loss of muscle mass observed in aged horses by increasing the availability of limiting amino acids (Graham-Thiers & Kronfeld, 2005) .
Many North American equine feed companies offer grain products that cater specifically towards aged horse populations, often called "senior feeds." Senior feeds often have components added to maintain weight, improve digestibility and support digestive and immune function of aged horses. Additionally, most common senior horse feeds include added essential amino acids that are known or suspected to be limiting, such as lysine, threonine and methionine.
When those senior horse feeds are fed at the recommended intakes prescribed by the manufacturer in combination with an adequate amount of good quality forage, those essential amino acid intakes are often above the NRC recommendation (NRC, 2007) . However, it is important to note that the published nutrient requirements for aged horses are not currently different from those of mature horses (NRC, 2007) , perhaps because there is not enough available research on differences in nutrient requirements between mature and aged horses. Therefore, it is possible that the requirements for essential amino acids are higher in aged horses and may not be met by current NRC recommendations for mature horses.
Although there are some data to support the idea that amino acid supplementation improves maintenance of muscle mass in aged horses (Graham-Thiers & Kronfeld, 2005) , the effects of amino acid supplementation on robust measures of protein metabolism, such as nitrogen retention and whole-body protein kinetics, have not been studied. Therefore, the objective of this study was to examine the effect of amino acid supplementation in aged horses on markers of whole-body and muscle protein metabolism.
| MATERIAL S AND ME THODS

| Animals, housing and feeding
All procedures used in this study were approved by the University of Kentucky Institutional Animal Care and Use Committee. Six aged horses (mean ± standard deviation; 20 ± 1.1 years old; 560 ± 40 kg;
5.6 ± 0.6 BCS; three mares and three geldings; four Thoroughbreds, one Quarter Horse, one Standardbred) were obtained from the University of Kentucky's Maine Chance Farm. Horses were housed individually in sawdust bedded (3.6 × 3.6 m) stalls overnight during the adaptation periods and during all sample collection procedures.
On day 0 to day 9 of each sampling period, horses were turned out together into a grass paddock, wearing grazing muzzles to prevent grass intake. Horses remained in stalls during the 72-hr urine and faeces collection and during the isotope administration procedures.
Body weights were taken following the morning meal on day 0, day 4, day 9 and day 14 of each collection period on a livestock scale (TI-500, Transcell Technology Inc., Buffalo Grove, IL). 
| Study design and procedures
Each period included a 9-day adaptation period with no washout period in between. On the morning of day 10 for each period, horses were fitted with a total urine and faeces harness (Equisan Nappy, South Melbourne, Australia) and all urine and faeces were collected for 72 hr to estimate nitrogen retention. Samples were collected every 4 hr and pooled into 24-hr sampling periods. Volume and weight of the urine and weight of faeces were recorded for each 4-hr sampling period. A subsample of urine (~100 ml) was collected into TA B L E 2 As-fed nutrient composition of feeds Ether soluble carbohydrates (%) 3.9 ± 0.9 2.9 ± 0.1 2.7 ± 0.6 2.6 ± 0.8
Starch (%) 0.7 ± 0.2 13.8 ± 0.9 11.3 ± 0.6 10.9 ± 0.6
Crude Fat (%) On day 13 and 14, muscle samples were taken from the gluteus medius using a specially designed Bergstrom needle (Urschel, Escobar, McCutcheon, & Geor, 2011) . On day 13, samples were collected before feeding the morning meal, while horses were in a postabsorptive state. On day 14, samples were collected 90 min after feeding the morning meal, while horses were in a postprandial state.
On the morning of day 15, a jugular vein catheter was placed, and stable isotope administration procedures were conducted as previously described (Mastellar, Barnes, Cybulak, & Urschel, 2016; Tanner et al., 2014) . Briefly, whole-body phenylalanine kinetics were determined by a 2-hr primed (5.3 μmol/kg) constant (4.4 μmol kg -1 hr −1 ) infusion of [ 13 C]sodium bicarbonate to measure total CO 2 production, immediately followed by 4-hr primed (10.3 μmol/kg) constant Horses were kept in a steady metabolic state for the entirety of the isotope administration procedures by feeding small portions of the daily meal every 30 min (Urschel, Geor, Hanigan, & Harris, 2012 Prime and constant oral doses of [1-13 C]phenylalanine administration were previously validated (Mastellar, Barnes, et al., 2016) .
The prime dose of [1- At the end of isotope administration procedures, the jugular vein catheter was removed, and horses were allocated to their next treatment at the evening meal. All horses were returned to the University of Kentucky's Maine Chance Farm herd after completion of the study.
| Blood sample processing
All blood samples were collected into 10-ml glass evacuated tubes containing sodium heparin (158 USP units; Becton-Dickinson), centrifuged at 1,500 × g for 10 min at 4°C, and then, plasma was frozen at −20°C until the time of analysis.
| Feed analysis
Samples of hay cubes and concentrates were collected during each period and analysed for nutrient content (Dairy One Cooperative
Inc.) using appropriate wet chemistry procedures. Additionally, feed samples were ground to particles smaller than 1 mm and subjected to acid hydrolysis in 6 M HCl (AOAC method 994). For the determination of feed methionine levels, feed samples underwent performic acid oxidation procedures prior to acid hydrolysis procedures.
Phenylisothiocyanate derivatives of the samples were prepared as previously described (Urschel et al., 2011) and were analysed by reverse-phase HPLC (3.9 × 300 mm PICO-TAG reverse-phase column, Waters, Milford, MA).
| Feed, urine and faeces nitrogen
The nitrogen content of the feeds (intra-assay CV 0.02%), urine (intra-assay CV 3.41%) and faeces (intra-assay CV 3.12%) samples was determined using an automated carbon/nitrogen analyser (Elementar C/N analyser). Nitrogen balance was calculated as the difference between nitrogen intake and the sum of nitrogen excretion in urine and faeces (nitrogen balance = nitrogen intake − (nitrogen loss in faeces + nitrogen loss in urine)).
| Plasma glucose, insulin, amino acids and urea nitrogen concentrations
Plasma glucose concentrations were determined by automated enzymatic assay using a YSI 2700 Select Analyser (YSI Inc., Life Sciences, Yellow Springs, OH) with an intra-assay CV of 1.53%.
Plasma insulin concentrations were determined using a Coat-ACount radioimmunoassay kit (Siemens, Munich, Germany) that has previously been validated for use in horses (Tinworth et al., 2011) , with an intra-assay CV of 10.7%. Plasma urea nitrogen concentrations were determined using a spectrophotometric assay, as described previously (Urschel, Rafii, Pencharz, & Ball, 2007) , with an intra-assay CV of 2.63%. Samples for analysis of glucose, insulin and urea nitrogen were within the linear range for the standard curve (2-15 mM, 3.91-371 uIU/ml and 2-8 mM respectively).
Plasma amino acid concentrations were determined via the HPLC analysis of the phenylisothiocyanate derivatives, as previously described (Urschel et al., 2011).
| Signalling pathways of muscle protein synthesis and degradation
Muscle samples were immediately homogenized in a lysis buffer, as previously described (Wagner & Urschel, 2012) , and stored at −80°C until the time of analysis. Muscle samples were analysed for the abundance and activation (phosphorylation) of proteins associated with the regulation of muscle protein synthesis (Akt, rpS6, AMPK) and degradation (Atrogin-1), by Western blotting, using previously described methods (Mastro, Adams, & Urschel, 2014; Wagner & Urschel, 2012) .
| Isotope enrichment
Breath samples were analysed for the ratio of 13 CO 2 to 12 CO 2 using an isotope ratio infrared spectrometer (IRIS-3; Wagner Analysen
Technik Vetriebs GmbH, Bremen, Germany).
Plasma samples were analysed by Metabolic Solutions Inc. (Nashua, NH) for [ 13 C]phenylalanine enrichment, as previously described (Wagner, Urschel, Betancourt, Adams, & Horohov, 2013) . Plasma (for phenylalanine administration) and breath (for phenylalanine and bicarbonate administration) isotopic enrichment plateaus were used to calculate the various phenylalanine kinetics parameters, as previously described (Mastellar, Barnes, et al., 2016; Tanner et al., 2014) .
| Statistics
Data were analysed using the mixed procedure of SAS (Version 9.4) with a model appropriate for a replicated Latin square design.
Plasma glucose, insulin, urea, amino acid concentrations, nitrogen balance, Western blot data, body weight and body condition were analysed using repeated measures analysis with treatment, period, time, treatment by time interaction and period by time interaction as the fixed effects, horse nested in period as the subject and time as the repeated variable. The variance/covariance matrix used was first-order autoregressive. Phenylalanine kinetics data were analysed using a one-way ANOVA, with treatment and period as the fixed effects and horse as a random effect. When model p-values were significant, means were separated using the Tukey-adjusted pdiff option. Statistical significance was considered at p < 0.05, and trends were considered at 0.05 < p < 0.10.
| RE SULTS
| Plasma glucose, insulin and urea nitrogen concentrations
In comparison with the CON treatment, LYS/THR was supple- (Table 3) . There was no effect of treatment (p > 0.05) or the treatment by time interaction (p > 0.05) on plasma glucose or insulin concentrations (Table 3) .
Plasma urea nitrogen concentrations in response to feeding were measured as an indicator of differences in the catabolism of dietary TA B L E 3 Pre-feeding (t = −30.0 min) and post-feeding (t = 30-240 min) plasma glucose, insulin and urea nitrogen concentrations in aged horses receiving concentrates with no amino acid supplementation (CON), lysine and threonine supplementation (LYS/THR) or lysine, threonine and methionine supplementation (LYS/THR/MET) indicate values that tend to be different (0.05 < p < 0.10) from the 0 min baseline sample where there is a significant fixed effect of time.
2 CON and LYS/THR/MET, n = 6; LYS/THR, n = 5. For the LYS/THR treatment, one horse's data were omitted due to a systemic infection.
amino acids between treatments. Samples were taken before and after a meal on day 12 of each period. PUN concentrations were not affected by time or treatment by time interaction (p > 0.05; Table 3 ).
PUN concentrations were affected by treatment, where concentrations tended to be higher for LYS/THR (p = 0.054) and were significantly higher for LYS/THR/MET (p = 0.0056) compared to CON.
| Plasma amino acid concentrations
After consuming the morning meal, the plasma concentrations of most amino acids increased (Table 4) . Plasma lysine and threonine concentrations were higher approximately 60 min after consuming a meal (p < 0.0001) for the horses receiving LYS/THR and LYS/ THR/MET compared to CON. Additionally, plasma methionine concentrations were higher (p = 0.012) in horses following consumption of LYS/THR as well as LYS/THR/MET (p < 0.0001) compared to CON (Table 4) . There was a significant treatment by time interaction for lysine, threonine and methionine, where plasma concentrations peaked earlier and more sharply when the amino acids were supplemented (Table 4) . Plasma leucine concentration tended to be higher for CON than LYS/THR/MET (p = 0.064).
Plasma phenylalanine concentration was higher for CON than Methionine CON 50 ± 6 49 ± 6 50 ± 6 58 ± 6 a 59 ± 6 a LYS/THR 53 ± 6 56 ± 6 67 ± 6 77 ± 7 79 ± 6 † LYS/THR/MET 61 ± 6 57 ± 6 68 ± 6 95 ± 6* ,b
94 ± 6* ,b
Histidine CON 84 ± 5 81 ± 5 81 ± 5 96 ± 5* 99 ± 5* LYS/THR 82 ± 5 75 ± 5 83 ± 5 92 ± 6* 91 ± 5* LYS/THR/MET 84 ± 5 81 ± 5 83 ± 5 93 ± 5* 98 ± 5* Isoleucine CON 92 ± 6 93 ± 6 97 ± 6 115 ± 6* 114 ± 6* LYS/THR 89 ± 7 89 ± 7 95 ± 7 106 ± 7* 107 ± 7* LYS/THR/MET 95 ± 6 91 ± 6 88 ± 7 106 ± 6* 108 ± 6* Leucine CON 176 ± 9 178 ± 9 183 ± 9 a 213 ± 9* Tryptophan CON 11 ± 2 8 ± 2 7 ± 2 9 ± 2 10 ± 2 LYS/THR 8 ± 2 7 ± 2 6 ± 2 7 ± 3 8 ± 2
LYS/THR/MET 7 ± 2 6 ± 2 9 ± 2 7 ± 2 12 ± 2 indicate values that tend to be different (0.05 < p < 0.10) from the 0 min baseline sample where there is a significant fixed effect of time.
LYS/THR/MET (p = 0.001) and tended to be higher for CON than LYS/THR (p = 0.069).
| Nitrogen retention
Nitrogen intakes and urinary and faecal nitrogen excretions were not significantly different between treatments (p > 0.05; and LYS/THR/MET (p = 0.093).
| Phenylalanine kinetics
Phenylalanine flux is the rate of entry and exit of phenylalanine from the free phenylalanine pool. Rate of phenylalanine entry into the pool is the sum of phenylalanine from the diet, and phenylala- 95 ± 5* 98 ± 5* 111 ± 6* 105 ± 6 † 98 ± 6 100 ± 6 100 ± 6 0.62 <0.0001 0.96 107 ± 7* 106 ± 7* 98 ± 7 100 ± 7 98 ± 7 110 ± 6* 103 ± 6 † 93 ± 6 96 ± 6 104 ± 6 † 203 ± 9* 194 ± 9 180 ± 9 182 ± 9 182 ± 9 0.047 <0.0001 0.98 194 ± 10* 190 ± 10* 175 ± 10 176 ± 10 172 ± 10 198 ± 9* 183 ± 9 163 ± 9 171 ± 9 181 ± 9 85 ± 3* 81 ± 3 78 ± 3 a 79 ± 3 78 ± 3 0.0013 <0.0001 0.88 82 ± 3* 80 ± 3* 76 ± 3 78 ± 3 76 ± 3 81 ± 3* 76 ± 3* 70 ± 3 b 74 ± 3 77 ± 3* 10 ± 2 12 ± 2 7 ± 2 8 ± 2 7 ± 2 0.27 0.44 0.65 9 ± 2 6 ± 2 6 ± 2 7 ± 2 11 ± 2 9 ± 2 7 ± 2 6 ± 2 6 ± 2 7 ± 2 protein synthesis). There was no significant effect of treatment on CO 2 production, phenylalanine flux, phenylalanine intake, phenylalanine oxidation, non-oxidative phenylalanine disposal or phenylalanine release from protein breakdown (p > 0.05; Table 6 ). However, the difference between non-oxidative phenylalanine disposal and phenylalanine release from protein breakdown was significantly negative for all three diets (CON, p = 0.0005; LYS/THR, p = 0.0005; LYS/THR/MET, p = 0.001).
| Muscle protein synthesis and degradation signalling
Akt and rpS6 proteins are associated with stimulation of protein synthesis signalling. rpS6 activation (amount of phosphorylated corrected for total) was significantly higher (p < 0.0001; Table 7 ) after meal feeding, but there was no significant effect of meal feeding on Akt activation (p = 0.11; Table 7 ). Additionally, there was no significant effect (p > 0.05; Table 7 ) of treatment, treatment by time interaction, period or period by time interaction on the activation of Akt or rpS6.
Atrogin-1 is a protein associated with muscle protein degradation. There was no significant effect of treatment or time on
Atrogin-1 abundance (p > 0.05; Table 7 ); however, there was a significant (p = 0.035) treatment by time interaction, where postfeeding CON abundance tended to be lower than pre-feeding CON abundance (p = 0.068).
AMPK is a protein associated with inhibition of protein synthesis signalling. There was no significant effect of treatment or time 
| D ISCUSS I ON
The treatments in this study provided 1.7% BW/day (DM) of forage cubes and 0.45% BW/day (DM) concentrate. They were designed to meet or exceed recommended nutrient intakes for mature horses at maintenance (NRC, 2007) . The hay cubes used were fed as directed by the manufacturer (1.5%-2% BW/day, as-fed), and the crude protein and lysine contents (11.1% and 0.43% respectively) were similar to the average content for mature cool season grass hay (10.8% and 0.38% respectively; NRC, 2007 Notes. Values are least squares means ± standard error. a CON and LYS/THR/MET, n = 6; LYS/THR, n = 5. For the LYS/THR treatment, one horse's data were omitted due to a systemic infection. b Nitrogen absorbed was calculated by taking the difference between nitrogen intake and faecal nitrogen excretion. c Nitrogen retained was calculated by taking the difference between nitrogen intake and the sum of faecal and urinary nitrogen excretion. TA B L E 5 Nitrogen consumption, urinary excretion, faecal excretion and nitrogen retention in aged horses receiving concentrates with no amino acid supplementation (CON), lysine and threonine supplementation (LYS/THR) or lysine, threonine and methionine supplementation (LYS/THR/MET) over a three-day collection period by treatment a than most commercially available senior feeds, and the supplemented concentrates had higher or similar amounts compared to commercially available senior feeds. Overall, digestible energy and crude protein were both provided well above the estimated requirements, by 33% and 105%, respectively, for mature horses (NRC, 2007) for all treatments. Because of this, it is likely that the horses on the CON treatment were already consuming more amino acids than they required, and it is unlikely that additional supplementation with amino acids above the CON intakes would have shown improvements in whole-body or muscle protein metabolism. These results demonstrate that nutrient requirements for aged horses are met when they are fed hay and concentrate at rates recommended by manufacturers and that additional amino acid supplementation may not be necessary. 9.9 ± 0.1 9.7 ± 0.1 9.7 ± 0.1 0.28
CON LYS/THR LYS/THR/MET
Phenylalanine released from protein breakdown (µmol kg −1 hr −1 )
49 ± 3 51 ± 4 52 ± 3 0.81
Phenylalanine leaving the free phenylalanine pool In the present study, all measured plasma amino acid concentrations except tryptophan were significantly affected by time and increased after feeding a meal. This confirms that dietary amino acids were being absorbed during the time of blood sampling. As expected, the plasma concentrations of lysine and threonine were greater in the horses that received diets supplemented with these amino acids, confirming that the supplemental amino acids were absorbed from the gastrointestinal tract. However, it is interesting to note that the supplementation of lysine and threonine in the diet also resulted in higher plasma methionine concentrations when compared to the control treatment. Elevated methionine concentrations in response to threonine supplementation have been previously documented in horses and have been suggested to result from negative feedback from threonine degradation (Mastellar, Moffet, Harris, & Urschel, 2016) .
To our knowledge, this is the first report of the measurement of nitrogen balance in aged horses. The lack of significant differences in nitrogen balance between treatments further supports the conclusion that there were no significant improvements in whole-body nitrogen metabolism when potentially limiting amino acids were supplemented in the diet of aged horses. Furthermore, the mean estimates for nitrogen retention were consistent, although not significantly negative, where both the LYS/THR and the LYS/THR/MET diets tended to have a negative nitrogen retention. In previous studies that examined nitrogen balance of mature horses at maintenance, horses were in positive nitrogen balances at nitrogen intake values greater than 0.3 g N kg −1 BW day −1 (Freeman, Potter, Schelling, & Kreider, 1988; Graham-Thiers & Bowen, 2014; Olsman, Jansen, Sloet van Oldruitenborgh-Oosterbaan, & Beynen, 2003). However, despite nitrogen intake being above that of most studies of mature horses at maintenance, nitrogen retention still tended to be negative in the current study, demonstrating a small net loss of nitrogen.
The horses in the current study did not lose a significant amount of weight over the 45-day experimental period, although the typical length of time over which body weight changes due to chronic illnesses such as muscle wasting are assessed is 6 months and therefore it is possible that the horses were not observed for a long enough period to show significant changes in body weight or composition.
Mean estimates of non-oxidative phenylalanine disposal (use for protein synthesis) were consistently lower than mean estimates of phenylalanine release from protein breakdown, which is in agreement with the consistently negative mean estimates of nitrogen balance data. Additionally, the difference between non-oxidative phenylalanine disposal and phenylalanine release from protein breakdown was significantly different from zero for all three diets, indicating that horses were breaking down protein faster than they were making it for all three diets. Previous studies have shown similar results, with values for phenylalanine release from protein breakdown being similar to or slightly higher than use for protein synthesis in aged horses (Mastro et al., 2014; Wagner et al., 2013) . Conversely, similar studies in growing (Mastellar, Moffet, et al., 2016) and mature horses show higher and similar rates of non-oxidative phenylalanine disposal than phenylalanine released from protein breakdown, respectively, indicating the that the growing horses were accreting body protein and the mature horses were maintaining body protein. (Katsanos et al., 2005) , which has been shown to be dependent on the amount of protein ingested in a single meal (Pennings et al., 2012) . Therefore, it is possible that in the present study, feeding small meals during isotope infusion did not result in a large enough anabolic response to correct the balance between protein synthesis and degradation in aged horses. However, considering both the negative net nitrogen balance measured over a 72-hr period, as well as the results of the stable isotope infusion, our data demonstrate that the horses in the present study were losing body protein faster than they were accreting it.
Akt is an upstream effector, and rpS6 is a downstream effector of mTOR, and both are proteins which when activated, promote protein synthesis. AMPK is a protein associated with the inhibition of mTOR signalling, and its activation is related to unfavourable cellular energy status. The significant increase in rpS6 activation in response to meal feeding shows that consuming a meal leads to increased protein synthesis as signalled by rpS6, but lack of effect of meal feeding on Akt suggests that the increase in activation may have been brought about by an upstream effector other than Akt. These results are similar to those found in previously published literature in horses (Urschel et al., 2011) . The lack of significant treatment effects on Akt, AMPK and rpS6 activation indicates that mTOR signalling was not significantly affected by supplementation of lysine and threonine or lysine, threonine and methionine. While addition of lysine and/or methionine have been shown to increase phosphorylation of rpS6 and Akt in the muscle under certain conditions, these results are typically observed during periods of protein deficiency, or in in vitro studies (Liu et al., 2017; Sato, Ito, & Nagasawa, 2015; Sato, Ito, Nedachi, & Nagasawa, 2014) .
Atrogin-1 is a protein associated with muscle protein degradation. There was a significant treatment by time interaction on the abundance of Atrogin-1, where the post-feeding CON abundance tended to be lower than pre-feeding CON abundance. However, there was no significant difference in pre-feeding and post-feeding abundance for the supplemented treatments. Similar results have been observed in in vitro studies of quail muscle fibroblasts, where treatment with methionine decreased Atrogin-1 expression (Tesseraud et al., 2007) . The decreased abundance of Atrogin-1 when samples were taken in a pre-feeding state during amino acid supplementation suggests that supplementation with lysine, threonine and methionine may have decreased signalling associated with muscle protein degradation while horses were in a post-absorptive state.
The lack of significant differences in nitrogen balance, phenylalanine kinetics and muscle mTOR signalling between treatment groups demonstrates that there was no change in whole-body protein synthesis or skeletal muscle accretion with supplementation of lysine and threonine or lysine, threonine and methionine.
The levels of lysine and threonine supplementation in the concentrates in the present study were selected based on those used in a previous study (Graham-Thiers & Kronfeld, 2005) , which resulted in improvements in other measures of protein status, specifically plasma urea nitrogen, 3-methylhistidine and creatinine concentrations and subjective muscle mass scores in exercising aged horses.
There are several potential reasons for the seemingly disparate results between the two studies. First, there was a higher crude protein, lysine, threonine and methionine content in the forage used in present study, compared to that used in the previous study.
Further, in the previous study, the treatments were not isonitrogenous (Graham-Thiers & Kronfeld, 2005) , whereas the diets in the current study were isonitrogenous. Therefore, improvements in the measures of protein metabolism in the previous study may have resulted from increased nitrogen intake, rather than a better balance of amino acids. Finally, the horses in the previous study were exercised, whereas the horses in the current study were sedentary. It is possible that in the previous study, the combination of protein or amino acid supplementation and anabolic effects of exercise could be responsible for the significant improvements observed, or that exercised horses in the previous study may have needed additional amino acids to support their greater level of activity Witard, McGlory, Hamilton, & Phillips, 2016) .
| CON CLUS ION
There were no improvements in nitrogen balance or phenylalanine kinetics with the supplementation of lysine, threonine and methionine to aged horses over a 15-day period. However, regardless of treatment, it appeared as though aged horses were losing body protein. Although there was improvement in a marker of muscle protein degradation with supplementation of lysine and threonine, as well as lysine, threonine and methionine, there was no evidence of improvements in the balance between protein synthesis and degradation with amino acid supplementation in the aged horses in the present study. Therefore, supplementation with lysine, threonine and methionine may not be necessary for sedentary, healthy aged horses receiving an adequate amount of average quality forage, and a concentrate designed for aged horses.
